PPT-CODE: TCS/16/31 RESEARCH
PROJECT BRIEFING KEY FINDINGS In the very early phase Bevacizumab does not alter resting or stimulated blood flow nor levels of the hormones ET1 or tPA The ET1 blocker
Download Presentation
"CODE: TCS/16/31 RESEARCH" is the property of its rightful owner. Permission is granted to download and print materials on this website for personal, non-commercial use only, provided you retain all copyright notices. By downloading content from our website, you accept the terms of this agreement.
Presentation Transcript
Transcript not available.